Cytomegalovirus infection following liver transplantation: Review of the literature

Clinical Infectious Diseases

Volumn 22, Issue 3, 1996, Pages 537-549

  Kanj, Souha S ^a   Sharara, Ala I ^b   Clavien, Pierre A ^b   Hamilton, John D ^b  

^a DUKE UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALLOGRAFT; CELLULAR IMMUNITY; CYTOMEGALOVIRUS INFECTION; GRAFT REJECTION; HIGH RISK POPULATION; HUMAN; INFECTION CONTROL; LIVER TRANSPLANTATION; MEDICAL LITERATURE; OPPORTUNISTIC INFECTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW;

EID: 0029782102     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinids/22.3.537     Document Type: Review

References (13)

1. Paya CV, Hermans PE, Washington JA II, et al. Incidence, distribution and outcome of episodes of infection in 100 orthotopic liver transplantations. Mayo Clin Proc 1989;64:555-64.
2. Singh N, Dummer JS, Kusne S, et al. Infections with cytomegalovirus and other herpesviruses in 121 liver transplant recipients: transmission by donated organ and the effect of OKT3 antibodies. J Infect Dis 1988;158:124-31.
3. Stratta RJ, Shaeffer MS, Markin RS, et al. Cytomegalovirus infection and disease after liver transplantation: an overview. Dig Dis Sci 1992;37:673-88.
4. McCarthy M, Karim M, Krueger H, Keown P. The cost impact of cytomegalovirus disease in renal transplant recipients [abstract]. J Am Soc Nephrol 1991;2:807.
5. Marin E, Wiesner R, Porayko M, et al. Cytomegalovirus infection after liver transplantation: incidence, timing and prediction of disease severity [abstract no 189]. J Hepatol 1991;13:550.
6. Rytel MW, Balay J. Cytomegalovirus infection and immunity in renal allograft recipients: assessment of the competence of humoral immunity. Infect Immun 1976;13:1633-7.
7. Rook AH. Interactions of cytomegalovirus with the human immune system. Rev Infect Dis 1988;10(suppl 3):S460-7.
8. Rand KH, Pollard RB, Merigan TC. Increased pulmonary superinfections in cardiac-transplant patients undergoing primary cytomegalovirus infection. N Engl J Med 1978;298:951-3.
9. Chatterjee SN, Fiala M, Weiner J, Stewart JA, Stacey B, Warner N. Primary cytomegalovirus and opportunistic infections: incidence in renal transplant recipients. JAMA 1978;240:2446-9.
10. George MJ, Snydman DR, Werner BG, et al. Cytomegalovirus disease as a risk factor for fungal disease in orthotopic liver transplant recipients [abstract no 32]. In: Program and abstracts of the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy (Anaheim, CA). Washington, DC: American Society for Microbiology, 1992.
11. O'Grady JG, Alexander GJM, Sutherland S, et al. Cytomegalovirus infection and donor/recipient HLA antigens: interdependent co-factors in pathogenesis of vanishing bileduct syndrome after liver transplantation. Lancet 1988;2:302-5.
12. Apperley JF, Goldman JM. Cytomegalovirus: biology, clinical features and methods for diagnosis. Bone Marrow Transplant 1988;3:253-64.
13. Betts RF, Freeman RB, Douglas RG Jr, Talley TE, Rundeil B. Transmission of Cytomegalovirus infection with renal allograft. Kidney Int 1975;8:385-92.